Screening for Colon CancerSurvey and Questionnaire
Investigational drug(s) / intervention(s)
Survey using a questionnaire.Survey using a questionnaire.
Survey using a questionnaire.: Preference questionnaire for colorectal cancer screening methods
Survey using a questionnaire.: Experience questionnaire into colorectal cancer screening programme
Study summary
The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:
* Values of experience of participants into screening programme.
* Values of preferences of participants for screening methods.
Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.
Eligibility
Sex
ALL
Min age
50 Years
Max age
69 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Participants ages from 50 to 69 years (both included) at the time of informed consent signed.
* Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center.
* Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.
Exclusion Criteria:
* Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form.
* Participants with a previous colonoscopy in consequence of a FOBT positive result.
* Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.
Primary outcome measure(s)
Value of questionnaires into screening programme — 12 months The percentage of number of answers from each experience and preference questions
Trial sites (2)
Facility
City
Region
Status
UCSP Sete Rios
Lisbon
Portugal
Not Yet Recruiting
CS Mar Báltico
Madrid
Madrid
Recruiting
More ADVANCED MARKER DISCOVERY S.L. trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
